Dr. Swati Goel, MD

Dr. Goel practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Goel's NPI, 1053632869, was assigned on June 15, 2010. Dr. Goel graduated from All India Institute of Medical Sciences in 2005. Dr. Goel holds New York license 269631.

Dr. Goel's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Goel's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Goel to 1 more group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goel practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Goel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Goel is licensed in New York.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Goel treats.

CMS data shows 235 Medicare services from Dr. Goel across 7 procedure codes in 2024, for 191 Medicare patients. Medicare paid $22,874 for them.

CMS counts 191 Medicare patients who saw Dr. Goel in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goel's median patient age at 67, with 61% women.

In 2024, Dr. Goel wrote 558 Medicare Part D claims for 79 patients. 34% of them were for generic drugs. CMS names the drug for 456 of them, across 11 drugs with 11 or more claims each, at $1,848,983 in total drug cost. In 2023, CMS named 488 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Goel for performance year 2024, reported as part of a group. CMS lists Dr. Goel as offering telehealth.

Dmand AI links 41 papers to Dr. Goel, published from 2013 to 2025. 2021 was the busiest year, with 8. The most frequent topics are COVID-19, SARS-CoV-2 and Cytokines. Dr. Goel has published most often in Leuk Lymphoma. Dr. Goel's most frequent co-authors are Kira Gritsman, MD, Noah Saul Kornblum, MD and Aditi Shastri, MD.

Dmand AI links Dr. Goel to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hematologic Diseases and Hemic and Lymphatic Diseases.

CMS Open Payments shows 37 general payments to Dr. Goel from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Novartis Pharmaceuticals Corporation paid the most, $226. It also lists 1 research payment totaling $125 in 2016.

Dr. Goel graduated from All India Institute of Medical Sciences in 2005.

Dr. Goel is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.